Physician profile
Gregory Thomas Stefano
NPI 1316155989
$1,661.97
in general payments reported to CMS, 2019-2025
19 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $86.68 · 2021: $153 · 2022: $245 · 2023: $228 · 2024: $405 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $607.71 | 2021-2024 | Onyx Frontier |
| Abiomed | $188.79 | 2022-2025 | Impella |
| Atricure, INC. | $123.57 | 2023-2025 | Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $111.65 | 2019-2024 | Camzyos, Eliquis |
| Pfizer INC. | $92.76 | 2019-2020 | |
| Boston Scientific Corporation | $65.88 | 2019-2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $62.97 | 2019-2023 | Brilinta |
| Terumo Medical Corporation | $53.67 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $49.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.11 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $43.50 | 2019-2025 | |
| Shockwave Medical, INC | $35.56 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $34.37 | 2020-2024 | Optis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.93 | 2019-2025 | Lifevest |
| Heartflow, INC. | $28.20 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $27.34 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $24.08 | 2019 | |
| Cordis US Corp. | $19.62 | 2023 | Saber |
| Portola Pharmaceuticals, LLC | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Stefano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.